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Abstract
Purpose To investigate the clinical impact of CT-guided biopsy, as performed in routine clinical practice, in patients with
suspected spondylodiscitis on MRI in terms of culture yield, impact on antimicrobial treatment, and outcome.
Methods This study included 64 patients with MRI findings compatible with spondylodiscitis who underwent CT-
guided biopsy.
Results Initial CT-guided biopsies were culture-positive in 20/64 (31.3%, 95% confidence interval [CI] 21.2–43.3%).
Repeat CT-guided biopsies (after initial negative biopsy) were culture-positive in an additional 5/15 (33.3%, 95% CI
15.2–58.3%). Serum leukocytes, C-reactive protein, pre-biopsy use of antibiotics, neurological symptoms, MRI findings,
vertebral height loss, and hyperkyphosis were not significantly different between culture-positive and culture-negative
cases (P = 0.214–1.000); 75% (15/20) of initial CT-guided biopsies that were culture-positive provided additional infor-
mation to clinicians for guiding antibiotic treatment. Sixty-two of 64 patients (96.9%, 95% CI 89.3–99.1%) would have
been adequately treated if a strategy was followed that would subject all patients without clinical findings suspicious for
Batypical^ microorganisms and negative blood cultures to empirical antibiotics (i.e., clindamycin for coverage of Gram-
positive bacteria) without using biopsy results to determine the optimal antibiotic regimen. Outcome within 6 months
(development of neurologic or orthopedic complications, surgery, and death) was not significantly different (P = 0.751)
between culture-positive and culture-negative patients.
Conclusions Although CT-guided biopsies are culture-positive in a minority of cases, the majority of positive cultures are useful
to tailor antibiotic treatment. Empirical treatment with clindamycin may cover almost all micro-organisms in positive biopsy
specimens, provided patients are not immunocompromised. Outcome appears similar between culture-positive and culture-
negative patients.
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Introduction
Spondylodiscitis refers to disc infection with adjacent verte-
bral body osteomyelitis [1]. The annual incidence of
spondylodiscitis in the Western world ranges from 0.4 to
2.4/100,000 [2]. Spondylodiscitis is a serious disease, causing
paralysis or motor weakness in around 25% of patients, with
some patients requiring surgery [1]. Furthermore, patients
with initially treated spondylodiscitis have a relapse rate
of spine infection of about 8% [1]. The overall attribut-
able mortality is approximately 6% [1]. Delay in diagno-
sis or management is regarded as detrimental to outcome
[2]. Nevertheless, the onset of spondylodiscitis-related
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symptoms is insidious and there is usually a delay in
diagnosis of 2–6 months after the start of symptoms [1,
2]. Magnetic resonance imaging (MRI) is regarded as the
imaging modality of choice for suspected spondylodiscitis
[3]. Infectious Diseases Society of America (IDSA)
guidelines strongly recommend to perform MRI before
biopsy [4, 5]. Furthermore, there is general consensus that
every effort should be made to establish a microbiological
diagnosis [1, 2]. Blood cultures have been reported to be
positive in approximately 58% of patients [6]. If blood
cultures remain negative after 48 h, it is recommended
to perform computed tomography (CT)-guided biopsy
[1, 2].
Some studies indicated that the positive culture rate of
CT-guided biopsies (calculated as the number of positive
cultures among all biopsy specimens) is rather disap-
pointing [7, 8], with reported percentages as low as
19.0% [8]. Recently, it was also reported that only 50%
of culture-positive CT-guided biopsies provided addition-
al information to clinicians for guiding antibiotic treat-
ment [8]. These recent data conflict with the results of
older studies, which reported positive CT-guided biopsy
cultures in up to 91% [9]. One potential reason for the
reported low culture yields is data contamination with
spondylodiscitis mimickers (such as Modic type I degen-
eration, acute Schmorl node, and (osteoporotic) fractures
[3]), and the inclusion of patients with a previous history
of spondylodiscitis (the post-treatment MRI findings are
non-specific and are known to frequently result in an
erroneous diagnosis of spondylodiscitis [10]). Serious
methodological biases are likely to explain the high cul-
ture yields reported in some previous studies. For exam-
ple, the study that reported a 91% positive CT-guided
biopsy culture yield excluded all patients with negative
blood and biopsy cultures to calculate this percentage
[9]. Moreover, the criteria used by clinicians for referral
of patients for CT-guided biopsy were unclear in that
study [9]. Therefore, further research is essential to de-
termine both the actual positive culture rate of CT-guided
biopsies and its impact on antimicrobiological treatment.
Another unknown issue is whether CT-guided biopsy re-
sults have any prognostic implications in terms of pro-
gressive neurologic and orthopedic complications, the
need for surgery, and mortality. If CT-guided biopsy
proves to have both a low pathogen detection rate with
limited treatment implications and no prognostic implica-
tions, the routine use of this invasive procedure may be
reconsidered.
The purpose of this study was therefore to investigate the
clinical impact of CT-guided biopsy, as performed in routine
clinical practice, in patients with suspected spondylodiscitis




The local institutional review board approved this retrospec-
tive study, and waived the requirement for informed consent.
The hospital’s database was searched for all patients who
underwent CT-guided biopsy because of suspected
spondylodiscitis between July 2008 and April 2017. Note that
the protocol in our hospital dictates that MRI should be per-
formed in all cases of suspected spondylodiscitis before biop-
sy is done, unless there are contra-indications for MRI. Patient
inclusion criteria were: MRI findings suggestive of
spondylodiscitis [3], the availability of a CT-guided biopsy,
and histological and microbiological examination of the ob-
tained tissue specimen. Patient exclusion criteria were: lack of
MRI within 2 months before CT-guided biopsy, MRI findings
suggestive of another condition than spondylodiscitis [3]),
CT-guided biopsies that were performed because of the suspi-
cion of a malignancy, previous history of spondylodiscitis,
CT-guided aspiration of paraspinal fluid collections without
anyMRI findings of spondylodiscitis, and CT-guided biopsies
that revealed malignancy.
MRI acquisition and evaluation
MRI scans were performed using various clinical 1.5-T MRI
systems. MRI acquisitions included sagittal and axial post-
gadolinium T1-weighted sequences, sagittal and axial T2-
weighted sequences, and fat-suppressed T2-weighted se-
quences, with slice thickness varying between 3 and 4 mm.
MRI scans were re-evaluated by a radiologist (T.C.K., with
6 years of experience in musculoskeletal MRI) who was
blinded to CT-guided biopsy results and follow-up data, using
a PACS workstation (Carestream Vue PACS version
11.4.1.1102, Carestream Health, Inc., Rochester, NY, USA).
MRI scans were reassessed to ensure that imaging findings
were compatible with spondylodiscitis and to exclude other
diseases such as Modic type I degeneration, acute Schmorl
node, ankylosing spondylitis, SAPHO syndrome, neuropathic
spine, and (osteoporotic) fractures. The MRI features for di-
agnosis of spondylodiscitis were used according to Hong et al.
[3]; (a) typical of spondylodiscitis: involvement (T2
hyperintensity and/or contrast enhancement after gadolinium
administration) of two consecutive vertebrae and the disc on
MRI; or (b) atypical of spondylodiscitis: involvement of only
one vertebral body, one vertebral body and one disc, two ver-
tebral bodies without the intervening disc, and any other pat-
tern. Presence or absence of paravertebral phlegmon (T2 hy-
perintense and uniformly enhancing tissue) and abscess (pe-
ripheral enhancement) was determined. Height of involved
vertebrae was semi-quantitatively assessed, according to the
method as described by Genant et al. [11], with > 40% height
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loss considered severe. Presence of hyperkyphosis of involved
vertebrae, defined as a kyphosis angle greater than 40° [12,
13], was also assessed. The latter two assessments were also
made for all available follow-up imaging examinations (in-
cluding conventional radiography, CT, and MRI) that were
performed after CT-guided biopsy. Note that 36 of 64 patients
who were eventually included had follow-up MRI scans, with
a median time span between biopsy and follow-up MRI of
5 months (range, 1–60 months).
CT-guided biopsy
CT-guided biopsy of the involved level of the spine was per-
formed by musculoskeletal-, interventional-, or neuroradiolo-
gists as part of routine clinical care. Core needle biopsy was
done in all patients. Core needle size ranged between 8 and 18
gauge, depending on the preference of the attending radiolo-
gist as determined for each patient individually. The number
of biopsies passes also depended on the attending radiologist’s
clinical judgment and the amount of tissue obtained. Acquired
tissue specimens were sent to both the pathology and micro-
biology department for further examination.
Pathological and microbiological examination
One of the attending musculoskeletal pathologists evaluated
the acquired biopsy specimen as part of routine clinical care,
with special attention to exclude other diseases than
spondylodiscitis, particularly malignancy. A medical microbi-
ologist (M.W.-B.) interpreted the culture results as clinically
relevant or suspicious of (skin) contamination. Additional se-
rology, mycobacterial cultures, or molecular analysis were
performed when clinically indicated, according to IDSA
guidelines [4, 5].
Statistical analysis
Culture yields of all initial CT-guided biopsies and repeat CT-
guided biopsies (after initial negative biopsy) were calculated,
along with 95% confidence intervals (CIs). Differences in
serum leukocyte and C-reactive protein (CRP) levels, pre-
biopsy use of antibiotics, neurological status (presence vs.
absence of neurological symptoms including peripheral neu-
ropathy and paraplegia), MRI findings (typical vs. atypical
MRI findings, and presence vs. absence of paravertebral
phlegmon and/or abscess, severe vertebral height loss, and
hyperkyphosis) were assessed between culture-positive and
culture-negative cases. The proportion of culture-positive
CT-guided biopsies that provided additional information to
clinicians for guiding antibiotic treatment (i.e., in those pa-
tients with negative blood cultures) was also calculated. In
addition, the proportion of patients in whom standard empir-
ical antibiotics would not cover the organism(s) that was/were
detected on CT-guided biopsy was determined. Differences in
outcome (defined as either development of severe vertebral
height loss, hyperkyphosis, neurological deficits, or need for
surgery within 6 months after CT-guided biopsy, and/or death
during hospitalization) was also assessed between patients
with positive and negative CT-guided biopsy cultures.
Differences between patients with positive and negative
CT-guided biopsy cultures were analyzed using two-tailed
unpaired t tests for normal distributed data, Mann–Whitney
tests for non-normal distributed data, and Fisher tests for di-
chotomous data. Kolmogorov–Smirnov tests were first used
to check whether continuous variables were normally distrib-
uted. P values less than 0.05 were considered statistically sig-
nificant. Statistical analyses were executed using MedCalc
version 17.2 Software (MedCalc, Mariakerke, Belgium).
Results
Patients
A total of 84 patients were potentially eligible for inclusion.
Of these 84 patients, eight were excluded because of previous
history of spondylodiscitis, four were excluded because of
MRI findings suggestive of another diagnosis than
spondylodiscitis (osteoporotic fractures [n = 2], acute
Schmorl node [n = 1], and a paravertebral mass of unknown
origin that was stable over the past 12 years [n = 1]) (Figs. 1
and 2)), three were excluded because no MRI was performed
to establish the diagnosis, two were excluded because of both
lack of recent (< 2 months) MRI and previous history of
spondylodiscitis, two were excluded because the obtained
CT-guided biopsy specimens were erroneously not sent to
the microbiological laboratory, and one was excluded because
of CT-guided aspiration of a paraspinal fluid collection with-
out any MRI findings of spondylodiscitis. Thus, 64 patients
(34 male and 30 female patients, with mean age of 61.7 ±
standard deviation [SD] ± 16.5 years, range, 16–91 years)
were finally included. The spondylodiscitis foci were local-
ized in the cervical (7.8%, 5/64), thoracic (28.1%, 18/64),
thoracolumbar (4.7%, 3/64), lumbar (42.2%, 27/64), and
lumbosacral (17.2%, 11/64) spine. Involvement of one,
two, three, and four vertebral-disc complexes was seen in
87.5% (56/64), 9.4% (6/64), 1.6% (1/64), and 1.6% (1/64)
patients, respectively. Sixteen patients (25%) had undergone
previous spinal surgery. Representative MRI images are
shown in Figs. 3 and 4.
Microbiological yield CT-guided biopsies
Twenty of 64 initial CT-guided biopsies (31.3%, 95% CI
21.2–43.3%) were culture-positive. From the 44 culture-
negative cases, a second CT-guided biopsy was performed
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in 15 cases, from which an additional five were culture-
positive (33.3%, 95% CI 15.2–58.3%). The isolated microor-
ganisms of both initial and additionally obtained biopsies are
displayed in Table 1. None of the biopsies showed any signs
of malignancy on histopathological examination. Arterial
bleeding occurred during one CT-guided biopsy, which was
successfully managed conservatively. No complications oc-
curred during the other 78 CT-guided biopsies. Table 1 shows
the microorganisms that were detected in the positive cultures.
There were no statistically significant differences in leuko-
cytes, CRP levels, use of antibiotics, neurological symptoms,
presence of typical MRI findings of spondylodiscitis,
paravertebral pleghmon/abscess, severe vertebral height loss,
and hyperkyphosis before biopsy between patients with posi-
tive and negative CT-guided biopsy cultures (P = 0.214–
1.000) (Table 2).
Impact of positive biopsy cultures on antimicrobial
treatment
In 46 of 64 biopsied patients (71.9%) blood cultures were also
obtained, which were positive in nine cases (19.6%, 95% CI
10.7–33.2%). The isolated microorganisms are depicted in
Table 1. Five of these latter nine cases were also culture-
posi t ive on CT-guided biopsy (al l for the same
microorganism) whereas four cases had positive blood cul-
tures but negative biopsy. Therefore, 75% (15/20) of initial
CT-guided biopsies that were culture-positive and 23.4%
(15/64) of all biopsies performed provided additional infor-
mation to clinicians for guiding antibiotic treatment. When
considering both culture-positive positive initial and culture-
positive repeat CT-guided biopsies, these proportions reached
80% (20/25) and 25.3% (20/79), respectively.
Assuming a standard empirical treatment for Gram-
positive bacteria with clindamycin, the microorganisms in
the biopsy specimens of 16 of 20 patients with positive biop-
sies but negative blood cultures would have been adequately
covered (i.e., positive biopsy results did not alter this empirical
treatment). Of the four remaining patients with positive biopsy
cultures, two were immunocompromised (of whom one pre-
sented with concomitant intestinal symptoms), which would
have alerted the clinicians that empirical treatment without
(positive) culture testing might not be adequate (Candida
crusei, and a combination Escherichia coli and Bacteroides
pyogenes were detected in these two patients). The two other
patients with positive biopsy cultures would not have been
covered with empirical antibiotics and had no clinical signs
to suggest Batypical^microorganisms (Candida albicans, and
a combination of Streptococcus salivarius, Streptococcus
species, and Neisseria species were detected in these two
a b c
Fig. 1 An 80-year-old woman with MRI findings consistent with
osteoporotic vertebral fractures. Sagittal T1-weighted (a), fat-suppressed
T2-weighted, and gadolinium-enhanced subtraction images (c) show
collapse of vertebrae T12 (continuous arrows) and T8 (dashed arrows),
with edema (b) and gadolinium enhancement of anterior and posterior
portions of the T12 vertebra (c), and the impression of some edema in
adjacent discs (b). However, there is no clear involvement of two
consecutive vertebrae. Moreover, the involvement of multiple levels
and the configuration of the affected vertebrae strongly suggest
osteoporotic vertebral fractures. This patient underwent CT-guided
biopsy with spondylodiscitis in the differential diagnosis of the original
clinical report, but was excluded from this study
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patients). Thus, 62 of the entire population of 64 patients
(96.9%, 95% CI 89.3–99.1%) would have been adequately
treated if a strategy was followed that would subject all pa-
tients without clinical findings suspicious for Batypical^ mi-
croorganisms and negative blood cultures to empirical antibi-
otics without using biopsy results to determine the optimal
antibiotic regimen.
Association with outcome
Thirteen of 64 patients (28.3%) had a poor outcome (four
patients developed severe vertebral collapse, three patients
required spinal surgery, two patients died during hospitaliza-
tion (the exact causes of death remained unclear), two patients
developed severe vertebral collapse and hyperkyphosis, one
patient developed paraplegia due to a new epidural abscess
(which could not be surgically treated due to the patient’s poor
condition), and one patient developed severe vertebral col-
lapse and hyperkyphosis and underwent spinal surgery).
However, there was no significant difference in outcome
(P = 0.751) between patients with positive CT-guided biopsy
cultures (6/25 patients with poor outcome) and negative CT-
guided biopsy cultures (7/39 patients with poor outcome)
(Table 2).
Discussion
The results of this study show that CT-guided biopsy in pa-
tients with MRI findings compatible with spondylodiscitis is
culture-positive in about one-third of patients, and that
this number is comparable for additional biopsies in
a b
c d
Fig. 2 A 54-year-old womanwith
MRI findings consistent with
acute Schmorl node. Sagittal T1-
weighted (a), fat-suppressed T2-
weighted (b), gadolinium-
enhanced T1-weighted (c), and
gadolinium-enhanced subtraction
images (d) show a focal
impression in the superior
endplate of the L3 vertebra with
surrounding pathological signal
intensity (arrows), but
involvement of only one endplate
and no diffuse signal intensity
abnormality of the adjacent disc.
This patient underwent CT-
guided biopsy with
spondylodiscitis in the differential
diagnosis of the original clinical
report, but was excluded from this
study
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primary culture-negative cases. The biopsy yield percent-
ages in this study may be more realistic than previously
reported numbers that suffered from methodological flaws
[7–9, 14], although local antibiotic resistance could
change yields between institutions. The same applies to
the investigation on the association of several laboratory,
clinical (including the pre-biopsy use of antibiotics), and
MRI findings with CT-guided biopsy results, with none of
them being statistically associated with a positive culture.
Positive CT-guided biopsies yielded additional informa-
tion to clinicians for guiding antimicrobial treatment in
75% of patients. These data seem to support the routine
use of CT-guided biopsy in patients with suspected
spondylodiscitis and negative blood cultures, in line with
general consensus [1, 2, 4, 5]. On the other hand, among
the entire population, all CT-guided biopsies were useful
to tailor antibiotic treatment in only 25% of patients.
Moreover, the present study found no significant differ-
ence in outcome between biopsy culture-positive and
culture-negative patients. A recent study by Kim et al.
[15] reported no significant difference (P = 0.157) in treat-
ment success (defined as survival and absence of signs of
infection at the end of the therapy) either between 75 patients
with microbiologically confirmed spondylodiscitis (whether
by means of blood or biopsy cultures) and 76 patients with-
out microbiologically confirmed spondylodiscitis. Given
the above-mentioned numbers, and the fact that (despite
being relatively safe, with transient complications in 2%
[16]) CT-guided biopsy is costly, invasive, and uses po-
tentially harmful ionizing radiation, the idea has been
coined to manage patients without clinical findings sus-
picious for Batypical^ pathogens with a course of em-
pirical antibiotic therapy, without performing CT-guided
biopsy [8]. Our data also showed that more than 95%
a
c d
bFig. 3 A 67-year-old man withMRI findings typical of
spondylodiscitis. Sagittal fat-
suppressed T2-weighted (a) and
gadolinium-enhanced T1-
weighed images (b) show
involvement of the L4 and L5
vertebrae (arrows), and also
increased T2 signal of the L4-L5
disc (a). Axial gadolinium-
enhanced T1-weighted image (c)
shows a paravertebral phlegmon
(arrowheads). CT-guided biopsy
was performed (d), with positive
cultures for Staphylococcus
warneri
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of patients would be adequately covered with antibiotics
with such a strategy. Potential drawbacks of such an
approach, however, are the risk antibiotic resistance de-
velopment and that it is less likely to be effective in
regions in which antimicrobial resistance is already a
major problem. Although further research on this topic
is necessary, it appears justifiable to consider such a
strategy when CT-guided biopsy is relatively contra-in-
dicated, for example in patients with hemorrhagic diath-
eses, in those who are anticipated to have problems
lying still during the procedure or require general anes-
thesia, and in settings in which there is no physician
available with expertise in CT-guided biopsy of the
spine. A future randomized prospective study, in which
an algorithm of clinical symptom criteria → blood cul-
ture and imaging criteria → biopsy → treatment will be
compared to an alternative algorithm of clinical symp-
tom criteria → blood culture and imaging → treatment,
would be of value to gain more insight into the utility
of CT-guided biopsies in spondylodiscitis. Importantly,
immunocompromised patients should be excluded from
such a study because these patients may present with
(opportunistic) micro-organisms that are not covered by
empirical antibiotics.
The present study had several limitations. First, due to its
retrospective design, there may have been selection bias.
Second, in the absence of a positive culture, there is no good
reference standard for spondylodiscitis. Although all MRI
scans were reviewed to exclude spondylodiscitis mimickers,
MRI does not reach 100% specificity [3], and it cannot be
excluded that non-spondylodiscitis cases were included.
Third, blood cultures were obtained in only 71.9% of patients.
Fourth, there was a lack of data to determine the effect of core
needle size, aspiration, and number of passes on quality and
volume of the biopsy specimen. Fifth, exact data on type and
duration of antibiotics use could not be retrieved, and their
effect on culture yields could not be assessed. Sixth, clinical
outcome was defined as loss of vertebral body stature, degree
of kyphosis, neurological deficits, need for surgery within
6 months, and death. However, these outcomes are likely mul-
tifactorial, and this analysis was not corrected for effects of
relevant variables such as degree of antibiotic resistance,
a b c
d e f
Fig. 4 A 88-year-old man with MRI findings atypical of
spondylodiscitis. Sagittal T1-weighted (a), fat-suppressed T2-weighted
(b), gadolinium-enhanced T1-weighted (d), and gadolinium-enhanced
subtraction images (e) show pathological signals in both the L2 and L3
vertebrae (arrows and arrowheads), but no clear T2 hyperintensity or
gadolinium enhancement of the L2–L3 disc. Axial T2-weighted (c) and
gadolinium-enhanced T1-weighted images (f) do not show any
paravertebral phlegmon or abscess either. CT-guided biopsy was
culture-negative
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medical history, age, and pre-existing spinal degenerative joint
disease.
In conclusion, although CT-guided biopsies are culture-
positive in a minority of cases, the majority of positive cul-
tures are useful to tailor antibiotic treatment. Empirical
treatment with clindamycin may cover almost all micro-
organisms in positive biopsy specimens, provided patients
are not immunocompromised. Outcome appears similar
between biopsy culture-positive and culture-negative
patients.
Table 1 Isolated microorganisms
Positive initial CT-guided biopsy cultures (n = 20) Positive repeated CT-guided biopsy cultures (n = 5) Positive blood cultures (n = 9)a,b
Propionibacterium acnes (n = 7)
Staphylococcus aureus (n = 3)
Enterococcus faecalis (n = 2)
Candida albicans (n = 1)
Candida crusei (n = 1)
Escherichia coli and Bacteroides species (n = 1)
Staphylococcus saccharolyticus (n = 1)
Streptococcus agalactiae (n = 1)
Streptococcus salivarius, Streptococcus species,
and Neisseria species (n = 1)
Streptococcus species (n = 1)
Streptococcus sanguinis (n = 1)
Staphylococcus aureus (n = 2),
Proprionibacterium acnes (n = 1)
Staphylococcus saprophyticus (n = 1)
Staphylococcus warneri (n = 1)
Staphylococcus aureus (n = 3)
Enterococcus faecalis (n = 2)
Bacteroides species (n = 1)
Staphylococcus epidermidis (n = 1)
Streptococcus gallolyticus (n = 1)
Parvimonas micra (n = 1)
a Five positive blood cultures were also culture-positive on CT-guided biopsy (all initial CT-guided biopsies), all for the same microorganism
(Staphylococcus aureus [n = 3] and Enterococcus faecalis [n = 2])
b Four positive blood cultures (Bacteroides species [n = 1], Staphylococcus epidermidis [n = 1], Streptococcus gallolyticus [n = 1], and Parvimonas
micra [n = 1]) were culture-negative on CT-guided biopsy
Table 2 Comparison of laboratory, clinical, and imaging features between patients with positive and negative CT-guided biopsy cultures
Parameter Positive CT-guided biopsy cultures (n = 25) Negative CT-guided biopsy cultures (n = 39) P value
Leukocytes (109/l) 9.9 ± 5.8a, p 9.6 ± 4.3a,q 0.801b
CRP (mg/ll) 73.8 ± 72.3a,p 62.8 ± 66.6a,r 0.555b
Pre-biopsy use of antibiotics 4/25 (16.0%, 95% CI 6.4–34.7%) 6/39 (15.4%, 95% CI 7.3–29.7%) 1.000c
Neurological symptoms 3/25 (12.0%, 95% CI 4.2–30.0%) 2/39 (5.1%, 95% CI 1.4–16.0%) 0.371c
Typical MRI findings of spondylodiscitis 22/25 (88.0%, 95% CI 70.0–95.8%) 28/39 (71.8%, 95% CI 56.2–83.5%) 0.214c
Paravertebral phlegmon and/or abscess 18/25 (72.0%, 95% CI 52.4–85.7%) 27/39 (69.2%, 95% CI 53.6–81.4%) 1.000c
Severe vertebral height loss* 3/25 (12.0%, 95% CI 4.2–30.0%) 1/39 (2.6%, 95% CI 0–13.2%) 0.291c
Hyperkyphosis** 0/25 (0%, 95% CI 0–13.2%) 1/39 (2.6%, 95% CI 0–13.2%) 1.000c
Poor outcome*** 6/25 (24.0%, 95% CI 11.5–43.4%) 7/39 (18.0%, 95% CI 9.0–32.7%)s 0.751c
aMean ± standard deviation (SD)
b Two-tailed unpaired t test
c Fisher’s exact test
dMedian with interquartile range between parentheses
eMann–Whitney test
p Two missing data
q Six missing data
r Five missing data
s One missing data
t Seven patients with negative cultures were not treated with antibiotics after CT-guided biopsy; none of them experienced a poor outcome. After
exclusion of these seven patients, there was still no significant difference in outcome between culture-positive and culture-negative patients (P = 1.000)
* > 40% vertebral height reduction
** Kyphosis angle greater than 40°
*** Development of new > 40% vertebral height reduction, hyperkyphosis, neurological deficits, or need for surgery within 6 months after CT-guided
biopsy, and/or death during hospitalization
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